Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
April 29th, 2022
2.2K views
We present a method for evaluating microRNA expression in the kidney and serum of mice with age-dependent renal impairment by quantitative reverse-transcription polymerase chain reaction.
Overview
This study presents a quantitative reverse-transcription polymerase chain reaction (qRT-PCR) method for evaluating microRNA expression in the kidney and serum of mice with age-dependent renal impairment. The technique allows for high accuracy and sensitivity in detecting microRNA expression, facilitating research in this area.
Key Study Components
Area of Science
- Neuroscience
- Biology
- MicroRNA research
Background
- MicroRNAs play a crucial role in gene regulation.
- Age-dependent renal impairment affects microRNA expression.
- Understanding microRNA profiles can provide insights into renal diseases.
- qRT-PCR is a widely used method for analyzing RNA expression.
Purpose of Study
- To evaluate microRNA expression in mice with renal impairment.
- To establish a reliable qRT-PCR method for serum and kidney samples.
- To identify specific microRNAs associated with age-related renal changes.
Methods Used
- Collection of serum and kidney samples from mice.
- Extraction of total RNA using phenol/guanidine-based lysis reagent.
- cDNA synthesis followed by qRT-PCR for microRNA quantification.
- Analysis of qRT-PCR data to determine expression levels of target microRNAs.
Main Results
- In SAMP1 mice, kidney levels of miRNA-7219-5p increased significantly.
- Kidney levels of miRNA-7218-5p decreased in SAMP1 mice.
- Serum levels of miRNA-7219-5p and miRNA-7218-5p were considerably increased.
- miRNA-223-3p levels remained unchanged in both strains.
Conclusions
- The qRT-PCR method effectively profiles microRNA expression in renal impairment.
- Specific microRNAs are associated with age-dependent renal changes.
- This method can be applied to investigate various pathological conditions.
Frequently Asked Questions
What is the significance of microRNA in renal impairment?
MicroRNAs regulate gene expression and can influence the progression of renal diseases.
How does qRT-PCR work?
qRT-PCR quantifies RNA levels by converting RNA to cDNA and amplifying it for detection.
What are the advantages of using this method?
It offers high sensitivity, accuracy, and a streamlined process for analyzing microRNA expression.
Can this method be used for other diseases?
Yes, it can be adapted to study microRNA expression in various pathological conditions.
What are the key microRNAs identified in this study?
miRNA-7219-5p, miRNA-7218-5p, and miRNA-223-3p were key focus areas in the study.
Is this method applicable to human samples?
While this study focuses on mice, the method can be adapted for human samples with appropriate modifications.
Executive Industry Relevance
Accurate microRNA expression profiling in kidney and serum enables early detection of age-dependent renal impairment mechanisms, supporting target validation in preclinical models. This qRT-PCR method provides quantitative, reproducible data that enhances predictive confidence in biomarker discovery pipelines. It addresses a critical gap in standardizing miRNA analysis for translational renal research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying miRNA-7218-5p and miRNA-7219-5p expression changes in kidney and serum.
- Operational Value: Provides a reliable method for extracting and evaluating miRNA from murine biological samples, reducing technical variability.
- Strategic Value: Supports biological de-risking of renal targets by clarifying miRNA dysregulation patterns in age-dependent impairment models.
Screening & Assay Development
- Scientific Value: Generates quantitative CT values from qRT-PCR, enabling standardized measurement of miRNA expression across sample types.
- Operational Value: Establishes a reproducible workflow for serum and kidney miRNA extraction, cDNA synthesis, and amplification.
- Strategic Value: Facilitates assay readiness for screening campaigns targeting miRNA-mediated pathways in renal disease models.
Translational & Preclinical Research
- Scientific Value: Clarifies the relationship between kidney and serum miRNA levels, supporting biomarker translation from tissue to biofluid.
- Operational Value: Enables longitudinal monitoring of miRNA-7218-5p and miRNA-7219-5p in preclinical models of renal impairment.
- Strategic Value: Supports risk-adjusted advancement decisions by providing mechanistic insights into age-related renal changes.
Pipeline & Workflow Integration
This method fits within the discovery continuum from target hypothesis testing to preclinical validation, particularly for renal fibrosis and aging-related pathways.
- Discovery Biology: Supports hypothesis testing by detecting significant changes in miRNA expression between control and impaired mouse strains.
- Screening: Delivers reproducible quantitative outputs (CT values) that enable comparison of miRNA levels across experimental conditions.
- Analytics: Uses comparative CT method with endogenous controls to normalize expression data, ensuring reliable inter-sample comparisons.
- Translational Research: Connects kidney miRNA alterations to detectable serum changes, supporting non-invasive biomarker development.
- Enterprise Reuse: Establishes a standardized protocol for miRNA quantification that can be reused across multiple renal disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation through precise, sensitive detection of miRNA expression changes.
- Operational Value: Enhances reproducibility and standardization across labs by defining clear RNA extraction and qRT-PCR steps.
- Strategic Value: Improves go/no-go decisions by providing mechanistic de-risking data on miRNA-driven renal pathways.
- Portfolio Impact: Enables risk-based prioritization of targets based on consistent miRNA dysregulation in preclinical models.
Implementation Considerations
- Requires expertise in RNA handling, reverse transcription, and qRT-PCR instrumentation.
- Depends on access to phenol/guanidine lysis reagents, spin columns, and real-time PCR systems with SYBR Green detection.
- Necessitates standardization of endogenous controls and reference samples across teams for comparative CT analysis.
- Involves adaptation considerations when applying the protocol to different mouse strains or sample volumes.
- Includes practical limitations such as the need for careful blood collection to avoid hemolysis and proper incubation times during extraction.
Biopharma FAQs
Why does qRT-PCR data normalization matter for target validation?
Normalization using endogenous controls ensures accurate comparison of miRNA expression levels between control and experimental groups, which is essential for validating therapeutic targets in renal impairment models.
How does isolating serum and kidney samples support independent variable control?
Separate extraction of serum and kidney samples allows researchers to isolate the impact of age-dependent renal impairment on each compartment, enabling clear assessment of tissue-specific versus systemic miRNA changes.
What do quantitative CT values enable in miRNA expression analysis?
Quantitative CT values from qRT-PCR allow precise measurement of miRNA expression levels, facilitating statistical comparison of expression changes between SAMR1 and SAMP1 mouse strains.
Why are replication requirements important for cross-functional collaboration?
Replicate samples and consistent PCR conditions ensure data reliability, which is critical for aligning discovery biology, assay development, and translational teams on target validation conclusions.
What statistical analysis is required before implementing this method in a discovery pipeline?
Comparative CT analysis with proper threshold selection and endogenous control normalization is required to accurately determine significant changes in miRNA expression, such as the increase in miRNA-7219-5p and decrease in miRNA-7218-5p observed in SAMP1 mice.
